16 Jun 2008   |   News

Neurology and psychiatry drugs available for partnering


Partnering opportunity

Jazz Pharmaceuticals, Inc of Palo Alto, California, is looking for partners for some its neurology and psychiatry drug development programmes, following a restructuring of the company.

“Reducing our overall R&D spending commitments and streamlining our administrative operations gives us additional flexibility in our requirements for future financing and we believe will shorten our timeline to reach profitability,” said Samuel Saks, CEO. “We are actively seeking partners for several of our development programmes.”


Never miss an update from Science|Business:   Newsletter sign-up